Form D/A - Notice of Exempt Offering of Securities: [Amend]

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form D/A - Notice of Exempt Offering of Securities: [Amend]

Allied (QB) (USOTC:ALID)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Allied (QB) Charts.

Allied (QB) (USOTC:ALID)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Allied (QB) Charts.

Allied Corp (QB) News

Form 15-12G - Securities registration termination [Section 12(g)]
Tuesday 11 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 5 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 22 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 14 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Wednesday 18 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Monday 16 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 18 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 15 October 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 24 September 2024 (5 months ago) • Edgar (US Regulatory)

Form D/A - Notice of Exempt Offering of Securities: [Amend]
Friday 9 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 18 July 2024 (8 months ago) • Edgar (US Regulatory)

More Allied Corp (QB) News Articles

Kraig Biocraft Laborator... (QB)

Asia Broadband (PK)

Cann American (CE)

Digital Brand Media and ... (PK)

Northwest Biotherapeutics (QB)

Lightwave Logic

Intergrated Cannabis Sol... (PK)

Good Vibrations Shoes (PK)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions